ContractExclusive License and Collaboration Agreement • September 17th, 2021
Contract Type FiledSeptember 17th, 2021Sarepta Therapeutics and Summit Enter Into Exclusive License and Collaboration Agreement for European Rights to Summit’s Utrophin Modulator Pipeline for the Treatment of Duchenne Muscular Dystrophy
ContractExclusive License and Collaboration Agreement • October 4th, 2016
Contract Type FiledOctober 4th, 2016Sarepta Therapeutics and Summit Enter Into Exclusive License and Collaboration Agreement for European Rights to Summit’s Utrophin Modulator Pipeline for the Treatment of Duchenne Muscular Dystrophy
ContractExclusive License and Collaboration Agreement • October 3rd, 2016
Contract Type FiledOctober 3rd, 2016Sarepta Therapeutics and Summit Enter Into Exclusive License and Collaboration Agreement for European Rights to Summit’s Utrophin Modulator Pipeline for the Treatment of Duchenne Muscular Dystrophy